Skip to main content

ITI Pharma and Healthcare Fund

Sectoral moderate Risk

Current NAV

₹18.44

1Y Return

--

3Y Return

--

5Y Return

--

AUM

--

Expense Ratio (Direct)

--

Category

Sectoral

Top Holdings

Top 20 stocks held by this fund as of May 2026 (Source: AMC monthly disclosure)

1

SUN PHARMACEUTICALS INDUSTRIES

Pharmaceuticals & Biotechnology

14.250%
2

DIVI LABORATORIES LTD

Pharmaceuticals & Biotechnology

8.430%
3

APOLLO HOSPITALS ENTERPRISE LT

Healthcare Services

6.200%
4

Laurus Labs Limited

Pharmaceuticals & Biotechnology

5.060%
5

Torrent Pharmaceuticals Limited

Pharmaceuticals & Biotechnology

4.900%
6

Max Healthcare Institute Limited

Healthcare Services

4.900%
7

Aurobindo Pharma Limited

Pharmaceuticals & Biotechnology

4.280%
8

Dr Reddys Laboratories Limited

Pharmaceuticals & Biotechnology

3.980%
9

Lupin Limited

Pharmaceuticals & Biotechnology

3.530%
10

Cipla Limited

Pharmaceuticals & Biotechnology

3.420%
11

Fortis Health Care Ltd

Healthcare Services

3.020%
12

Neuland Laboratories Limited

Pharmaceuticals & Biotechnology

3.000%
13

Alkem Laboratories Limited

Pharmaceuticals & Biotechnology

2.880%
14

Cohance Lifesciences Limited

Pharmaceuticals & Biotechnology

2.650%
15

Abbott India Limited

Pharmaceuticals & Biotechnology

2.030%
16

Mankind Pharma Limited

Pharmaceuticals & Biotechnology

1.950%
17

Aster DM Healthcare Limited

Healthcare Services

1.790%
18

Sai Life Sciences Limited

Pharmaceuticals & Biotechnology

1.630%
19

Shaily Engineering Plastics Limited

Consumer Durables

1.470%
20

IPCA Laboratories Limited

Pharmaceuticals & Biotechnology

1.440%

📋 All returns shown are for Direct-Growth plan. Data from AMC monthly portfolio disclosure.

SIP in ITI Pharma and Healthcare Fund

If you had invested ₹10,000/month via SIP:

1 Year SIP

₹127,200

Invested: ₹1,20,000

3 Year SIP

₹403,200

Invested: ₹3,60,000

5 Year SIP

₹744,000

Invested: ₹6,00,000

Calculate exact SIP returns →

Invest in ITI Pharma and Healthcare Fund

Start SIP from ₹500/month on these platforms

More Sectoral Funds

About Sectoral Funds

Sectoral mutual funds are a category defined by SEBI (Securities and Exchange Board of India) under their mutual fund categorization framework. These funds invest primarily in equities that match the sectoral profile, with specific allocation mandates that fund managers must follow. The category determines the fund's risk-return characteristics and its suitability for different investor profiles.

When evaluating a Sectoral fund like ITI Pharma and Healthcare Fund, key metrics to consider include: 3-year and 5-year CAGR (rolling returns are more reliable than point-to-point), expense ratio (Direct plans have lower costs), portfolio turnover, standard deviation (volatility measure), Sharpe ratio (risk-adjusted returns), and alpha generation over benchmark. A fund that consistently beats its benchmark index over multiple market cycles is a strong candidate.

For long-term wealth creation, Sectoral funds work best with a systematic investment plan (SIP) over 5+ years. SIP helps average out market volatility through rupee cost averaging. Lump sum investments are better timed during market corrections. Always ensure your mutual fund portfolio is diversified across 3-4 categories rather than concentrating in a single fund type. Consult a SEBI-registered investment advisor for personalized advice based on your financial goals and risk appetite.

Frequently Asked Questions

Is ITI Pharma and Healthcare Fund good for SIP?

ITI Pharma and Healthcare Fund is a Sectoral fund with moderate risk. For SIP investors, consistency of returns matters more than absolute returns. Check the fund's rolling returns and standard deviation before committing to a SIP. Sectoral funds are generally suitable for SIP with a minimum 5-year investment horizon for optimal results.

What is the risk level of this fund?

ITI Pharma and Healthcare Fund is categorized as moderate risk as per SEBI's riskometer methodology. This assessment considers market cap allocation, sector concentration, and historical portfolio volatility. This risk level indicates relatively stable returns with moderate portfolio fluctuation.

How to invest in this fund?

You can invest in ITI Pharma and Healthcare Fund (Direct-Growth plan) through platforms like Groww, Zerodha Coin, Kuvera, or directly from the AMC website. Minimum SIP amount starts at ₹500/month on most platforms. Complete KYC (PAN + Aadhaar verification) is mandatory before your first investment.

What are the tax implications?

For equity mutual funds in India: Short-term capital gains (units held less than 1 year) are taxed at 20%. Long-term capital gains (held more than 1 year) above ₹1.25 lakh in a financial year are taxed at 12.5%. ELSS funds have a mandatory 3-year lock-in period. Dividend income from mutual funds is added to your income and taxed at your applicable slab rate.